Ángela Rodríguez-Trillo

403 citations
13 papers · 176 indexed · h-index 8

Ángela Rodríguez-Trillo

13 papers receiving 175 citations

Peers

Ángela Rodríguez-Trillo
Comparison fields: 5 of 40
  • Hematology 91
  • Genetics 22
  • Nephrology 14
  • Immunology 39
  • Rheumatology 25
Replace Teresa Sevivas with:
Teresa Sevivas Portugal
Ioanna Dialoupi Greece
Jingliao Zhang China
Yasuhiro Taniguchi Japan
I. M. Nesbitt United Kingdom
María Perera Spain
Lucie Grodecká Czechia
Yafei Yu China
Jean-Pierre David Germany
José Antonio Queizán Spain
Ángela Rodríguez-Trillo relative to Teresa Sevivas Portugal Teresa Sevivas's profile →
Citations per field
00.5×1.5×
Teresa Sevivas · 1×
Citations per year

Countries citing papers authored by Ángela Rodríguez-Trillo

Since Specialization
Citations

This map shows the geographic impact of Ángela Rodríguez-Trillo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ángela Rodríguez-Trillo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ángela Rodríguez-Trillo more than expected).

Fields of papers citing papers by Ángela Rodríguez-Trillo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ángela Rodríguez-Trillo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ángela Rodríguez-Trillo. The network helps show where Ángela Rodríguez-Trillo may publish in the future.

Co-authorship network

The 18 scholars most cited alongside Ángela Rodríguez-Trillo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ángela Rodríguez-Trillo Line = papers co-authored together Ángela Rodríguez-Trillo links everyone, so they are left out of the graph.

All Works

13 of 13 papers shown
#Work
1 20224
2 202212
3 20227
4 202036
5 20199
6 20186
7 20171
8 201421
9 201427
10 20117
11 201112
12 200928
13 20096

About Ángela Rodríguez-Trillo

Ángela Rodríguez-Trillo is a scholar working on Hematology, Rheumatology and Immunology and Allergy, having authored 13 papers that have together received 176 indexed citations. Recurring topics across this work include Platelet Disorders and Treatments (6 papers), Rheumatoid Arthritis Research and Therapies (4 papers), Antiplatelet Therapy and Cardiovascular Diseases (3 papers), Blood groups and transfusion (3 papers), Retinoids in leukemia and cellular processes (2 papers), Blood disorders and treatments (2 papers), Autoimmune and Inflammatory Disorders Research (2 papers) and interferon and immune responses (1 paper). The work is most often cited by research in Hematology (91 citations), Genetics (22 citations) and Nephrology (14 citations). Ángela Rodríguez-Trillo has collaborated with scholars based in Spain, Netherlands and Ireland. Frequent co-authors include Almudena Pérez‐Rodríguez, Javier Batlle, María Fernanda López Fernández, Carmen Conde, Antonio Mera, Antonio González, Francisco J. Blanco, Eva Pérez‐Pampín, Samuel García and José J. Cuenca‐Castillo. Their work appears in journals such as Scientific Reports, Journal of Pharmacology and Experimental Therapeutics and Frontiers in Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026